Schwartz SS, et al: Use of an glucose controlled insulin infusion system (artifical beta cell) to control diabetes during surgery. Diabetologia 16(157-164), 1979.
Schwartz SS, et al: Familial nesidioblastosis: severe neonatal hypoglycemia in two families. Journal of Pediatrics 95(44-53), 1979.
Horowitz DD, Schwartz SS: Diabetes related surgery and obstetrics. Hormone and Metabolic Research, Supplement #18(156-158), 1979.
Green DA, Brown MJ, Braunstein SN, Schwartz SS, et al: Comparison of clinical course and sequential electrophysiological tests in diabetes with symptomatic polyneuropathy and its implications for clinical trials. Diabetes 30(139-147), 1981.
Snape WJ Jr, Battle WM, Schwartz SS, Braunstein SN, et al: Metoclopramide to treat gastroparesis due to diabetes mellitus. Annals of Internal Medicine 96(444), April 1982.
Nesler CL, Sinclair SH, Schwartz SS, Gabbe SG: Diabetic Neuropathy in Pregnancy. Clinics in Obstetrics and Gynecology, Vol.28 #3(pp528-535). Saunders and Company, Philadelphia, 1985.
Sinclair SH, Nesler CL, Schwartz SS: Retinopathy in the Pregnant Diabetic. Clinics in Obstetrics and Gynecology, Vol.28 #3(pp536-552). Saunders and Company, Philadelphia, 1985.
Parkman HP, Schwartz SS: Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch. Internal Medicine, Vol.147(1477-1480), 1987.
Grunwald JE, Brucker AJ, Schwartz SS, et al: Diabetic Glycemic Control and Retinal Blood Flow. Diabetes 39.5, May 1990.
Broderick GA, Schwartz SS: Erectile Dysfunction in Diabetes. Hospital Practice 26(8), August 1991.
Maschak-Carey, Schutta M, Schwartz SS, et al: Successful Implementation of a Comprehensive Diabetes Disease Management Program in an Integrated Academic Health Care System. Disease Management 2(43), 1999.
Schwartz SS, et al: Nutrition and Diabetes. Medical Nutrition and Disease, 2nd. Morrison and Hark (eds.). 1999.
Shutta M, Schwartz SS: Insulin Resistance and Diabetic Complications. Preventive Medicine in Managed Care 2(1): S3-S19, 2001.
Schwartz SS: Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. Current Medical Research and Opinion 24: 3009-3022, 2008.
Schwartz SS: Synergy in diabetes treatment. Review in Endocrinology, Nov 2008.
Salber PR, Bestermann W, Schwartz SS, Marchetti A: Loss of confidence in diabetes management. Manag Care. 17(10): 38, 2008.
Grant SF, Hakonarson H, Schwartz SS: Can the Genetics of Type 1 and Type 2 Diabetes Shed Light on the Genetics of Latent Autoimmune Diabetes in Adults? Endocr Rev. [Epub ahead of print] PubMed PMID: 20007922. Nov 2009.
Kohl BA, Schwartz SS: Surgery in the patient with endocrine dysfunction. Anesthesiology Clinics 27(4), 2009.
Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS: American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 15(6), 2009.
Kohl BA, Schwartz SS: Medical Care for Endocrine patients for surgery. Anesthesiology Clinics, 2010.
Schwartz SS, Kohl BA: Type 2 Diabetes Mellitus and the Cardiometabolic Syndrome: Impact of Incretin-Based Therapies. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. July 2010.
Schwartz SS: Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled by diet, exercise and insulin administration. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. July 2010.
Schwartz SS, Kohl BA: Glycemic control and weight reduction while avoiding hypoglycemia: the case for the continued safe aggressive care of patients with type 2 diabetes. Mayo Clinic Proc. 85(12 suppl):S15-26, Dec 2010.
Fabricatore A, Schwartz SS, et al: Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. Diabetes Research and Clinical Practice. In press.
Schwartz, Fabricatore, Diamond, Weight Reduction in Diabetes, Book Chapter “Diabetes: An Old Disease, a New Insight,” edited by Dr. Ahmad., Landes Bioscience, June, 2012
Schwartz,SS Scheiner G,, “Role of CGMS in the management of type 1 and type 2 diabetes” in Evidence-based Management of Diabetes (Vora, Buse, Eds.), 2013
Schwartz SS, Defronzo, R, Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients with Type 2 Diabetes, DIABETES CARE , 36:2107, July 2013
Schwartz SS, Optimizing Glycemic Control While Minimizing the Risk of Hypoglycemia in Patients With Type2 Diabetes Mellitus, Drugs in Context, may, 2013
Schwartz,SS,, A Practice Based Approach to the 2012 Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes, Current Medical Research & Opinion, 4/24/2013 e.pub
Bose S, Krishnamoorthy P, Varanasi A, Nair J, Schutta M, Braunstein S, Iqbal N, Schwartz S, St Clair C, Master SR, Rader DJ, Reilly MP, Mehta NN,.Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokines.,Obesity (Silver Spring). 2013 Jan;21(1):E118-23. doi: 10.1002/oby.20086.
Umpierrez,G, Schwartz SS Use of incretin-based Therapy in hospitalized Patients with Hyperglycemia, submitted 2013
Stanley Schwartz , Ralph Defronzo, The Use of Non-Insulin Anti-Diabetic Agents to Improve Glycemia Without Hypoglycemia in the Hospital Setting: Focus on Incretins,Journal: Current Diabetes Reports; DOI: 10.1007/s11892-013-0466-9
Schwartz, Umpierrez , Defronzo, Incretin Use in Hospital Care of Diabetes , Annals Internal Medicine, submitted 1/2014
Draznin et al, Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action",
Diabetes Care, 36:2107, July 2013
Schwartz, SS. Do many folks with T2D REALLY need insulin?, in Case Studies in DM, (ed. Draznin, B.), 2014, accepted